NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/28/2024
Back to search
Official data from USPTO
UTC THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/28/2024
Trademark type
Combined
Nice classes
5
Filing date
07/20/2022
Registration date
05/28/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/28/2024
Last transaction
05/28/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-01-00
First use in commerce
2023-01-00
Drawing code
3
Owner type
99
Owner location
Shanghai,, CN
Examiner
LE, KHANH M
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "UTC THERAPEUTICS" and a stylized design of a figure composed of a circle above a triangular shape with curved sides all appearing inside an incomplete circle.
Holders and representatives
Holders
UTC Therapeutics (Shanghai) CO., LTD.
Representatives
Yue (Robert) Xu APEX ATTORNEYS AT LAW, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for the treatment of cancer; Cells for medical or clinical use; Diagnostic biomarker reagents for medical purposes; Gene therapy productsgenetically engineered tissues for transplant purposes; Living cells for medical use; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Reagents for use in medical genetic testing; Solutions for medical and clinical use in storing and treating cellsblood and blood components; Anti-cancer preparations
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/25/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/24/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/09/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/06/2024
IUAF
USE AMENDMENT FILED
03/19/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/19/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/26/2023
PUBO
PUBLISHED FOR OPPOSITION
09/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/22/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/18/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/18/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/18/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/31/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2023
GNRT
NON-FINAL ACTION E-MAILED
05/05/2023
CNRT
NON-FINAL ACTION WRITTEN
05/05/2023
DOCK
ASSIGNED TO EXAMINER
05/04/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2022
NWAP
NEW APPLICATION ENTERED
07/23/2022
Continuous trademark protection
Get notified about every new filing that threatens UTC THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.